Targeted Delivery of Cisplatin to Lung Cancer Using ScFvEGFR-Heparin-Cisplatin Nanoparticles-Reference-Cited by-同舟云学术

Targeted Delivery of Cisplatin to Lung Cancer Using ScFvEGFR-Heparin-Cisplatin Nanoparticles

Published:2011-11-04 Issue:12 Volume:5 Page:9480-9493
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Peng Xiang-Hong¹,Wang Yiqing¹,Huang Donghai¹,Wang Yuxiang¹,Shin Hyung Juc¹,Chen Zhengjia¹,Spewak Michael B.¹,Mao Hui¹,Wang Xu¹,Wang Ying¹,Chen Zhuo (Georgia)¹,Nie Shuming¹,Shin Dong M.¹

Affiliation:

1. Department of Hematology and Medical Oncology, ‡Department of Biomedical Engineering, §Winship Cancer Institute, ⊥Quest Diagnostics, ∥Department of Biostatistics and Bioinformatics, and ¶Department of Radiology, Emory University School of Medicine, Atlanta, Georgia 30322, United States.

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/nn202410f

Reference59 articles.

1. Platinum Drug Distribution in Cancer Cells and Tumors

2. The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy

3. Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods

4. Cisplatin: a review of toxicities and therapeutic applications

5. Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of anti-lung cancer in nude mice by a fully human single-chain antibody against associated antigen Ts7TMR between A549 cells and Trichinella spiralis;Artificial Cells, Nanomedicine, and Biotechnology;2024-05-16

2. Design and Evaluation of a Humanized Anti-EGFR huscFv Antibody Fragment in Combination With Metformin in A549 CellsIn Vitro;Anticancer Research;2024-04-27

3. Physiologically driven nanodrug delivery system for targeted lung cancer treatment;Exploration of Medicine;2024-04-25

4. Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance;Journal of Molecular Structure;2024-04

5. Nano‐Engineering Strategies for Tumor‐Specific Therapy;ChemMedChem;2024-03-04